Since CRP is one of the acute phase proteins derived from hepatocytes stimulated by circulating interleukin 6 (IL-6), CRP levels in cancer patients reflect the amount of IL-6 in the circulating blood produced by T-cells or macrophages. This evidence concerns the gene IL6 and cancer.